EFFECTS OF CORONARY ANGIOPLASTY ON PLASMA PLATELET-ACTIVATING-FACTOR IN MAN

被引:0
|
作者
ELDAR, M
LYSKO, PG
SCHULHOFF, N
GAGNON, RC
FEUERSTEIN, G
SHANI, J
机构
[1] MAIMONIDES HOSP,DEPT CARDIOL,BROOKLYN,NY 11219
[2] SMITHKLINE BEECHAM PHARMACEUT,DEPT PHARMACOL,KING OF PRUSSIA,PA
来源
JOURNAL OF LIPID MEDIATORS | 1992年 / 5卷 / 03期
关键词
PAF; CORONARY ANGIOPLASTY; ISCHEMIA; MYOCARDIAL;
D O I
暂无
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Platelet activating factor (PAF) is a mediator of ischemia and reperfusion-induced tissue damage which was found to be synthesized in culture by endothelial cells. We hypothesized that PAF levels may be increased in the coronary system following coronary angioplasty. PAF levels were measured in the great cardiac vein of 16 patients before, during and following angioplasty of the left anterior coronary artery. PAF concentration was significantly higher in the cardiac vein than in the peripheral circulation at all time points. Interestingly, while PAF levels tended to decrease in the periphery they tended to increase in the coronary system over time. We conclude that PAF levels are higher in the coronary system than in the peripheral circulation in patients undergoing coronary angioplasty and that PAF may be released into the coronary artery following the procedure.
引用
收藏
页码:313 / 319
页数:7
相关论文
共 50 条
  • [31] PLATELET-ACTIVATING-FACTOR AND ASTHMA
    MORLEY, J
    AGENTS AND ACTIONS, 1986, 19 (1-2): : 100 - 108
  • [32] ANTAGONISTS OF PLATELET-ACTIVATING-FACTOR
    TOKUMURA, A
    TSUKATANI, H
    SEIKAGAKU, 1985, 57 (12): : 1618 - 1623
  • [33] PLATELET-ACTIVATING-FACTOR ANTAGONISTS
    SAUNDERS, RN
    HANDLEY, DA
    ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY, 1987, 27 : 237 - 255
  • [34] RADIOIMMUNOASSAY FOR PLATELET-ACTIVATING-FACTOR
    KARASAWA, K
    SATOH, N
    HONGO, T
    NAKAGAWA, Y
    SETAKA, M
    NOJIMA, S
    LIPIDS, 1991, 26 (12) : 1126 - 1129
  • [35] PLATELET-ACTIVATING-FACTOR AND ISCHEMIA
    POTRON, G
    PETITFRERE, E
    NGUYEN, P
    CLINICAL HEMORHEOLOGY, 1993, 13 (02): : 155 - 176
  • [36] PLATELET-ACTIVATING-FACTOR RECEPTOR
    IZUMI, T
    TAKANO, T
    BITO, H
    NAKAMURA, M
    MUTOH, H
    HONDA, Z
    SHINIZU, T
    JOURNAL OF LIPID MEDIATORS AND CELL SIGNALLING, 1995, 12 (2-3): : 429 - 442
  • [37] THE PROMISE OF PLATELET-ACTIVATING-FACTOR
    BRAQUET, P
    MENCIAHUERTA, JM
    CHABRIER, PE
    TOUQUI, L
    VARGAFTIG, BB
    ISI ATLAS OF SCIENCE-PHARMACOLOGY, 1987, 1 (03): : 187 - 198
  • [38] BIPHASIC EFFECTS OF PLATELET-ACTIVATING-FACTOR ON CORONARY BLOOD-FLOW IN ANESTHETIZED DOG
    MEHTA, J
    WARGOVICH, T
    NICHOLS, WW
    PROSTAGLANDINS LEUKOTRIENES AND MEDICINE, 1986, 21 (01): : 87 - 95
  • [39] PLATELET-ACTIVATING-FACTOR AND THE VASCULAR EFFECTS OF ZYMOSAN IN RATS
    DAMAS, J
    REMACLEVOLON, G
    BOURDON, V
    EUROPEAN JOURNAL OF PHARMACOLOGY, 1993, 231 (02) : 231 - 236
  • [40] EFFECTS OF PLATELET-ACTIVATING-FACTOR ON MOUSE SPERM FUNCTION
    SENGOKU, K
    ISHIKAWA, M
    TAMATE, K
    SHIMIZU, T
    JOURNAL OF ASSISTED REPRODUCTION AND GENETICS, 1992, 9 (05) : 447 - 453